Bridgefront Capital »

Ocular Therapeutix shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $367k 43k 8.47
2021-06-30 $243k 17k 14.18

More positions owned by Bridgefront Capital

Take-Two Interactive Software (TTWO)
TPG Com Cl A (TPG)
Constellation Brands Cl A (STZ)
Broadcom (AVGO)
Encana Corporation (OVV)
Kimberly-Clark Corporation (KMB)
Clorox Company (CLX)
Lamb Weston Hldgs (LW)
Keysight Technologies (KEYS)
EQT Corporation (EQT)
Celsius Hldgs Com New (CELH)
Amgen (AMGN)
Micron Technology (MU)
Host Hotels & Resorts (HST)
Agree Realty Corporation (ADC)

View all positions for Bridgefront Capital

Top funds holding Ocular Therapeutix

FMR
Deep Track Capital
BlackRock
venBio Select Advisor
Summer Road
VR Adviser
Vanguard Capital Management
Point72 Asset Management
State Street Corporation
Geode Capital Management
Alliancebernstein
Logos Global Management
Octagon Capital Advisors
Balyasny Asset Management
Commodore Capital

View all funds holding Ocular Therapeutix